IIB
118th CONGRESS
2d Session
H. R. 3884
IN THE SENATE OF THE UNITED STATES
September 24, 2024
Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions
AN ACT
To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.
Short title
This Act may be cited as the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
.
Reauthorization of sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment
Section 1106(b) of the Public Health Service Act (42 U.S.C. 300b–5(b)) is amended—
in paragraph (3)(A), by inserting , grant, or cooperative agreement
after contract
; and
in paragraph (6), by striking $4,455,000 for each of fiscal years 2019 through 2023
and inserting $8,205,000 for each of fiscal years 2024 through 2028
.
Passed the House of Representatives September 23, 2024.
Kevin F. McCumber,
Clerk.